Effectdossier · gearchiveerd kwartaal
APLS
Apellis Pharmaceuticals, Inc. · Healthcare · Biotechnology
16Gevolgde houders
+2Δ houders
43.69MGehouden aandelen
$756.24MGerapporteerde waarde
+2Nieuwe posities
−0Uitstappen
Momentum-inputs (vergelijkbare managers):
breedte van houders +14.3% ·
aandelenstroom +5.2% ·
netto nieuwe posities +12.5%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q1 2026 | 99 | +3 | 79.10M | $3.12B | +14 | −12 |
| Q4 2025 | 97 | +1 | 73.39M | $1.84B | +2 | — |
| Q3 2025 | 19 | +1 | 50.24M | $1.14B | +1 | −1 |
| Q2 2025 | 16 | +2 | 43.69M | $756.24M | +2 | — |
| Q1 2025 | 11 | -2 | 24.93M | $545.30M | +1 | −3 |
| Q4 2024 | 13 | +2 | 23.82M | $760.24M | +3 | −1 |
| Q3 2024 | 10 | +2 | 20.37M | $587.46M | +2 | — |
| Q2 2024 | 8 | — | 21.17M | $811.69M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 10.15M | — | $175.78M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 10.15M | — | $175.78M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 10.15M | — | $175.78M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passief) | 10.15M | — | $175.78M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passief) | 10.15M | — | $175.78M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 8.98M | -27.0% | $155.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Wellington Management ✦ | 8.98M | -27.0% | $155.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Wellington Management ✦ | 8.98M | -27.0% | $155.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 9 | Wellington Management ✦ | 8.98M | -27.0% | $155.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Wellington Management ✦ | 8.98M | -27.0% | $155.39M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | BlackRock ✦ (passief) | 6.40M | — | $110.87M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | AQR Capital Management ✦ | 5.98M | +46.6% | $103.45M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 29 | AQR Capital Management ✦ | 5.98M | +46.6% | $103.45M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 30 | AQR Capital Management ✦ | 5.98M | +46.6% | $103.45M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 31 | AQR Capital Management ✦ | 5.98M | +46.6% | $103.45M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 5.98M | +46.6% | $103.45M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 33 | State Street Global Advisors ✦ (passief) | 3.56M | -9.6% | $61.67M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 34 | Marshall Wace ✦ | 2.70M | +11373.8% | $46.82M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 35 | Norges Bank ✦ (passief) | 2.37M | +50.4% | $40.98M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Geode Capital Management ✦ (passief) | 2.00M | +2.3% | $34.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 37 | Geode Capital Management ✦ (passief) | 2.00M | +2.3% | $34.54M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 38 | Citadel Advisors ✦ | 442.56K | +97.5% | $7.66M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Citadel Advisors ✦ | 442.56K | +97.5% | $7.66M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 40 | Two Sigma Investments ✦ | 406.91K | +54.8% | $7.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 41 | D. E. Shaw & Co. ✦ | 251.07K | Nieuw | $4.35M | 0.0% | New | 1 | SEC ↗ |
| 42 | Millennium Management ✦ | 202.45K | -55.2% | $3.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | Gotham Asset Management ✦ | 119.23K | +247.8% | $2.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 44 | T. Rowe Price ✦ | 92.15K | +1.6% | $1.60M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 19.29K | — | $333,939 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 19.29K | — | $333,939 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Renaissance Technologies ✦ | 10.99K | Nieuw | $190,202 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| D. E. Shaw & Co. | $4.35M | 0.0% |
| Renaissance Technologies | $190,202 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 320 houders, 137.95M aandelen, $5.43B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API